ml-3000 has been researched along with mk 767 in 2 studies
Studies (ml-3000) | Trials (ml-3000) | Recent Studies (post-2010) (ml-3000) | Studies (mk 767) | Trials (mk 767) | Recent Studies (post-2010) (mk 767) |
---|---|---|---|---|---|
130 | 9 | 56 | 32 | 0 | 10 |
Protein | Taxonomy | ml-3000 (IC50) | mk 767 (IC50) |
---|---|---|---|
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.463 | |
Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.914 | |
ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.463 | |
ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.463 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morphy, R; Rankovic, Z | 1 |
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 review(s) available for ml-3000 and mk 767
Article | Year |
---|---|
Designed multiple ligands. An emerging drug discovery paradigm.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chemistry, Pharmaceutical; Dopamine D2 Receptor Antagonists; Drug Design; Humans; Ligands; Metabolic Diseases; Peroxisome Proliferator-Activated Receptors; Receptors, Histamine H1; Selective Serotonin Reuptake Inhibitors | 2005 |
1 other study(ies) available for ml-3000 and mk 767
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |